INTEGRATED BIOPHARMA, INC.

Company

INTEGRATED BIOPHARMA INC

Filed

September 28, 2004

Period of Report

June 30, 2004

Accession Number

0001016504-04-000069

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →